A9576 HCPCS Level II code: Injection, gadoteridol, (prohance multipack), per ml
A9576 is the HCPCS code for “Injection, gadoteridol, (prohance multipack), per ml” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
A9576Injection, gadoteridol, (prohance multipack), per ml
Short description: Inj prohance multipack
HCPCS · United States
Medicare details
The indicators CMS publishes with A9576 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Diagnostic radiology
- BETOS category
- Standard imaging - nuclear medicine
- Added
- Jan 1, 2008
Where A9576 sits
- 1A codesAmbulance, supplies and miscellaneous
- 2Active code A9576Injection, gadoteridol, (prohance multipack), per ml
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code A9576 mean?
A9576 is the HCPCS code for “Injection, gadoteridol, (prohance multipack), per ml” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover A9576?
CMS lists A9576’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside A9576
All A codesA9570Indium in-111 labeled autologous white blood cells, diagnostic, per study doseA9571Indium in-111 labeled autologous platelets, diagnostic, per study doseA9572Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuriesA9573Injection, gadopiclenol, 1 mlA9574Injection, ferumoxytol, 1 mgA9575Injection, gadoterate meglumine, 0.1 mlA9577Injection, gadobenate dimeglumine (multihance), per mlA9578Injection, gadobenate dimeglumine (multihance multipack), per mlA9579Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per mlA9580Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuriesA9581Injection, gadoxetate disodium, 1 mlA9582Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries